Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.
Mesh Bio has raised $3.5M in total funding. The most recent round was Series A. The last funding was announced in October 2023.
Mesh Bio's investors include Seed Capital, East Ventures, Elev8.VC, Seeds Capital, Selvedge Venture.
Mesh Bio is headquartered in Bukit Merah, Singapore.
Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.
Mesh Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mesh Bio — Funding & Investors." VCBacked, October 12, 2023, https://www.vcbacked.co/company/mesh-bio. Accessed September 3, 2026.
VCBacked. (2023). Mesh Bio — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/mesh-bio
{{cite web |title=Mesh Bio — Funding & Investors |url=https://www.vcbacked.co/company/mesh-bio |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated